TIGIT and HIV-1 infection: We previously showed that TIGIT also marks CD8 + T cells unable to respond to MDDC stimulation (Calvet-Mirabent et al, 2022) and the fate of these cells in vivo during HIV-1 infection and in response to anti-TIGIT antibodies should be assessed in the future.